Skip to main content
. 2017 Mar 14;2017(3):CD010806. doi: 10.1002/14651858.CD010806.pub2

1. Description of populations.

Trial Country Age (years) On antiretroviral therapy (ART) General population or subgroup Mood disorders
Inclusion criteria Exclusion criteria
Antoni 2006 USA 18 to 65 Yes Homosexual men None stated Current psychosis or panic disorder
Antoni 2008 USA 18 to 60 Not stated Women with evidence of CIN1 None stated Current major psychiatric illness
Berger 2008 Switzerland 18 to 65 Yes General population None stated Current major psychiatric disorder
Carrico 2005 USA Not stated No (recruited
largely during the era prior to highly active antiretroviral therapy (HAART; 1992 to 1997)
Homosexual men None stated Current major psychiatric illness
Jones 2010 USA > 18 Not stated Minority women None stated Untreated major psychiatric illness
McCain 2003 USA > 18 Yes General population None stated Significant psychiatric illness
Safren 2012 USA 18 to 65 Yes Prior intravenous drug users Current depressive mood disorder Untreated or unstable major mental illness
Heckman 2007 USA Not stated Not stated Rural population No inclusion or exclusion criteria related to psychological functioning were employed No inclusion or exclusion criteria related to psychological functioning were employed
Heckman 2011 USA > 50 Not stated Individuals over the age of 50 BDI‐II score is minimum 10 Exclude severe depression or cognitive impairment
Sikkema 2013 USA Not stated Not stated History of child sexual abuse Not stated Not stated
Peltzer 2012 South Africa > 18 Yes Individuals with ART adherence problem/new antiretroviral (ARV) medication users (6 to 24 months of ARV use) Not stated Not stated
Chesney 2003 USA 21 to 60 No Homosexual men Reported depressed mood 10 or higher on CES‐D scale Major depressive disorder or other psychotic disorders
Bormann 2006 USA 18 to 65 Not stated Adult men and women (50% homosexual) Not stated Cognitive impairment of active psychosis
Duncan 2012 USA Not specified Yes Adult men and women who reported
 distress associated with side effects from ART treatment Reporting a level of side effect‐related bother for the previous 30 days at or above eight (corresponding to the 40th percentile in another sample) on the side effect and symptom distress scale Severe cognitive impairment,
 active psychosis, or active substance abuse
Gayner 2012 Canada Not specified Not stated Homosexual men None stated Active current major depression, substance abuse, or significant cognitive deficit
Nakimuli‐Mpungu 2015 Uganda > 19 Not stated Both men and women People with major depression on Mini Psychiatric Interview Scale The trial excluded individuals with a severe medical disorder such as pneumonia or active tuberculosis, psychotic symptoms, and hearing or visual impairment.

Abbreviations: ART: antiretroviral therapy; ARV: antiretroviral.